Science Translational Medicine · 2010 · 47 citations · 28 references
Life SciencesBiochemistryMolecular MedicineBiomedical ImagingDiagnostic ImagingMetabolomicsCancer MetabolomicsMagnetic Resonance SpectroscopyMetabolite IdentificationMetabolite ProfilingNuclear Magnetic Resonance MetabolomicsProstate BiopsyMetabolite Distribution AnalysisMetabolite ImagingMetabolome Data AnalysisMetabolomic BiomarkersMetabolomic SignaturesNuclear Magnetic Resonance Spectroscopy-based Metabolite ProfilingProstate Metabolism
As current radiological approaches cannot accurately localize prostate cancer in vivo, biopsies are conducted at random within prostates for patients at risk for prostate cancer, leading to high false-negative rates. Metabolomic imaging can map cancer-specific biomolecular profile values onto anatomical structures to direct biopsy. In this preliminary study, we evaluated five whole prostates removed during prostatectomy from biopsy-proven cancer patients on a 7-tesla human whole-body magnetic resonance scanner. Localized, multi-cross-sectional, multivoxel magnetic resonance spectra were used to construct a malignancy index based on prostate cancer metabolomic profiles obtained from previous intact tissue analyses with a 14-tesla spectrometer. This calculated malignancy index is linearly correlated with lesion size and demonstrates a 93 to 97% overall accuracy for detecting the presence of prostate cancer lesions, suggesting the potential clinical utility of this approach.
28
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole, E. David Crawford, Robert L. Grubb et al. · New England Journal of Medicine · 2009 · 2.9K citations · Full text
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar, Laila Poisson, Thekkelnaycke M. Rajendiran et al. · Nature · 2009 · 2.2K citations · Full text
Medicine, Cancer Biology, Oncology +16